COVID-19

Attacking the defence: SARS-CoV-2 can infect immune cells

Subjects

Lymphopenia and systemic viral dissemination are commonly found in severe COVID-19. This preprint study reports that immune cells (monocytes, CD4+ T cells, CD8+ T cells and B cells) are susceptible to SARS-CoV-2 infection. This was observed by in vitro infection of immune cells and by ex vivo detection of SARS-CoV-2 in peripheral blood mononuclear cells from patients with severe COVID-19. Post-mortem in situ analysis of lung tissues further confirmed the presence of infected immune cells in COVID-19. As monocytes and lymphocytes do not express ACE2, it remains to be seen whether the virus uses an alternative entry strategy and whether circulating infected immune cells contribute to viral spread and COVID-19 disease progression.

References

Original article

  1. Pontelli, M. C. et al. Infection of human lymphomononuclear cells by SARS-CoV-2. Preprint at bioRxiv https://doi.org/10.1101/2020.07.28.225912 (2020)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Mariana Borsa or Julie M. Mazet.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Borsa, M., Mazet, J.M. Attacking the defence: SARS-CoV-2 can infect immune cells. Nat Rev Immunol 20, 592 (2020). https://doi.org/10.1038/s41577-020-00439-1

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing